ATE353650T1 - Kombinationstherapie zur behandlung von krebs - Google Patents
Kombinationstherapie zur behandlung von krebsInfo
- Publication number
- ATE353650T1 ATE353650T1 AT03712464T AT03712464T ATE353650T1 AT E353650 T1 ATE353650 T1 AT E353650T1 AT 03712464 T AT03712464 T AT 03712464T AT 03712464 T AT03712464 T AT 03712464T AT E353650 T1 ATE353650 T1 AT E353650T1
- Authority
- AT
- Austria
- Prior art keywords
- cancer
- treatment
- effective amount
- combination therapy
- warm
- Prior art date
Links
Classifications
-
- A—HUMAN NECESSITIES
- A61—MEDICAL OR VETERINARY SCIENCE; HYGIENE
- A61K—PREPARATIONS FOR MEDICAL, DENTAL OR TOILETRY PURPOSES
- A61K31/00—Medicinal preparations containing organic active ingredients
- A61K31/33—Heterocyclic compounds
- A61K31/395—Heterocyclic compounds having nitrogen as a ring hetero atom, e.g. guanethidine or rifamycins
- A61K31/495—Heterocyclic compounds having nitrogen as a ring hetero atom, e.g. guanethidine or rifamycins having six-membered rings with two or more nitrogen atoms as the only ring heteroatoms, e.g. piperazine or tetrazines
- A61K31/505—Pyrimidines; Hydrogenated pyrimidines, e.g. trimethoprim
- A61K31/517—Pyrimidines; Hydrogenated pyrimidines, e.g. trimethoprim ortho- or peri-condensed with carbocyclic ring systems, e.g. quinazoline, perimidine
-
- A—HUMAN NECESSITIES
- A61—MEDICAL OR VETERINARY SCIENCE; HYGIENE
- A61K—PREPARATIONS FOR MEDICAL, DENTAL OR TOILETRY PURPOSES
- A61K31/00—Medicinal preparations containing organic active ingredients
- A61K31/16—Amides, e.g. hydroxamic acids
- A61K31/165—Amides, e.g. hydroxamic acids having aromatic rings, e.g. colchicine, atenolol, progabide
-
- A—HUMAN NECESSITIES
- A61—MEDICAL OR VETERINARY SCIENCE; HYGIENE
- A61K—PREPARATIONS FOR MEDICAL, DENTAL OR TOILETRY PURPOSES
- A61K31/00—Medicinal preparations containing organic active ingredients
- A61K31/66—Phosphorus compounds
- A61K31/661—Phosphorus acids or esters thereof not having P—C bonds, e.g. fosfosal, dichlorvos, malathion or mevinphos
-
- A—HUMAN NECESSITIES
- A61—MEDICAL OR VETERINARY SCIENCE; HYGIENE
- A61P—SPECIFIC THERAPEUTIC ACTIVITY OF CHEMICAL COMPOUNDS OR MEDICINAL PREPARATIONS
- A61P35/00—Antineoplastic agents
-
- A—HUMAN NECESSITIES
- A61—MEDICAL OR VETERINARY SCIENCE; HYGIENE
- A61P—SPECIFIC THERAPEUTIC ACTIVITY OF CHEMICAL COMPOUNDS OR MEDICINAL PREPARATIONS
- A61P43/00—Drugs for specific purposes, not provided for in groups A61P1/00-A61P41/00
-
- A—HUMAN NECESSITIES
- A61—MEDICAL OR VETERINARY SCIENCE; HYGIENE
- A61P—SPECIFIC THERAPEUTIC ACTIVITY OF CHEMICAL COMPOUNDS OR MEDICINAL PREPARATIONS
- A61P9/00—Drugs for disorders of the cardiovascular system
- A61P9/10—Drugs for disorders of the cardiovascular system for treating ischaemic or atherosclerotic diseases, e.g. antianginal drugs, coronary vasodilators, drugs for myocardial infarction, retinopathy, cerebrovascula insufficiency, renal arteriosclerosis
Applications Claiming Priority (2)
Application Number | Priority Date | Filing Date | Title |
---|---|---|---|
GB0208680A GB0208680D0 (en) | 2002-04-16 | 2002-04-16 | Combination therapy |
GB0218388A GB0218388D0 (en) | 2002-08-08 | 2002-08-08 | Combination therapy |
Publications (1)
Publication Number | Publication Date |
---|---|
ATE353650T1 true ATE353650T1 (de) | 2007-03-15 |
Family
ID=29252451
Family Applications (1)
Application Number | Title | Priority Date | Filing Date |
---|---|---|---|
AT03712464T ATE353650T1 (de) | 2002-04-16 | 2003-04-14 | Kombinationstherapie zur behandlung von krebs |
Country Status (17)
Country | Link |
---|---|
US (1) | US20050215530A1 (de) |
EP (1) | EP1496909B1 (de) |
JP (1) | JP2005530735A (de) |
KR (1) | KR20040103964A (de) |
CN (1) | CN100352441C (de) |
AT (1) | ATE353650T1 (de) |
AU (1) | AU2003216558B2 (de) |
BR (1) | BR0309226A (de) |
CA (1) | CA2482591A1 (de) |
DE (1) | DE60311788T2 (de) |
ES (1) | ES2280735T3 (de) |
HK (1) | HK1071310A1 (de) |
IL (1) | IL164564A0 (de) |
MX (1) | MXPA04010166A (de) |
NO (1) | NO20044498L (de) |
NZ (1) | NZ535739A (de) |
WO (1) | WO2003088971A1 (de) |
Families Citing this family (15)
Publication number | Priority date | Publication date | Assignee | Title |
---|---|---|---|---|
GB0218526D0 (en) * | 2002-08-09 | 2002-09-18 | Astrazeneca Ab | Combination therapy |
EP1658084A2 (de) * | 2003-06-18 | 2006-05-24 | Angiogene Pharmaceuticals Ltd | Zusammensetzungen enthaltend zd6126 zusammen mit 5-fu, cpt-11 oder 5-fu und cpt-11 mit gefässschädigender aktivität und deren verwendung zur behandlung von kolorecktalemkarcinoma |
CA2542481A1 (en) * | 2003-10-15 | 2005-04-28 | Osi Pharmaceuticals, Inc. | Imidazopyrazine tyrosine kinase inhibitors |
US7534797B2 (en) | 2004-04-02 | 2009-05-19 | Osi Pharmaceuticals, Inc. | 6,6-Bicyclic ring substituted heterobicyclic protein kinase inhibitors |
EP1768963A4 (de) * | 2004-06-03 | 2009-06-10 | Smithkline Beecham Cork Ltd | Krebsbehandlungsverfahren |
RU2006146612A (ru) | 2004-06-03 | 2008-07-20 | Ф.Хоффманн-Ля Рош Аг (Ch) | Лечение цисплатином и ингибитором рецептора эпидермального фактора роста (egfr) |
US20060084666A1 (en) * | 2004-10-18 | 2006-04-20 | Harari Paul M | Combined treatment with radiation and an epidermal growth factor receptor kinase inhibitor |
FR2886151B1 (fr) * | 2005-05-31 | 2007-09-07 | Mayoly Spindler Soc Par Action | Utilisation de la colchicine pour la preparation d'un medicament destine a la prevention et/ou au traitement de l'endometriose |
US8575164B2 (en) * | 2005-12-19 | 2013-11-05 | OSI Pharmaceuticals, LLC | Combination cancer therapy |
US20110046144A1 (en) * | 2008-01-18 | 2011-02-24 | Mulvihill Mark J | Imidazopyrazinol derivatives for the treatment of cancers |
WO2009143051A1 (en) * | 2008-05-19 | 2009-11-26 | Osi Pharmaceuticals, Inc. | Substituted imidazopyr-and imidazotri-azines |
EP2408479A1 (de) | 2009-03-18 | 2012-01-25 | OSI Pharmaceuticals, LLC | Kombinationskrebstherapie mit verabreichung eines egfr-hemmers und eines igf-1r-hemmers |
MX2011011025A (es) | 2009-04-20 | 2011-11-02 | Osi Pharmaceuticals Llc | Preparacion de c-piracin-metilaminas. |
JP2012526138A (ja) * | 2009-05-07 | 2012-10-25 | オーエスアイ・ファーマシューティカルズ,エルエルシー | 副腎皮質癌を治療するためのosi−906の使用 |
WO2012129145A1 (en) | 2011-03-18 | 2012-09-27 | OSI Pharmaceuticals, LLC | Nscle combination therapy |
Family Cites Families (5)
Publication number | Priority date | Publication date | Assignee | Title |
---|---|---|---|---|
AU661533B2 (en) * | 1992-01-20 | 1995-07-27 | Astrazeneca Ab | Quinazoline derivatives |
GB9508538D0 (en) * | 1995-04-27 | 1995-06-14 | Zeneca Ltd | Quinazoline derivatives |
GB9714249D0 (en) * | 1997-07-08 | 1997-09-10 | Angiogene Pharm Ltd | Vascular damaging agents |
EE200200565A (et) * | 2000-03-31 | 2004-06-15 | Angiogene Pharmaceuticals Ltd. | Vaskulaarse kahjustava toimega kombinatsioonravi |
GB0008269D0 (en) * | 2000-04-05 | 2000-05-24 | Astrazeneca Ab | Combination chemotherapy |
-
2003
- 2003-04-14 AT AT03712464T patent/ATE353650T1/de not_active IP Right Cessation
- 2003-04-14 AU AU2003216558A patent/AU2003216558B2/en not_active Ceased
- 2003-04-14 CN CNB03813702XA patent/CN100352441C/zh not_active Expired - Fee Related
- 2003-04-14 KR KR10-2004-7016666A patent/KR20040103964A/ko not_active Application Discontinuation
- 2003-04-14 NZ NZ535739A patent/NZ535739A/en unknown
- 2003-04-14 MX MXPA04010166A patent/MXPA04010166A/es active IP Right Grant
- 2003-04-14 BR BR0309226-7A patent/BR0309226A/pt not_active IP Right Cessation
- 2003-04-14 EP EP03712464A patent/EP1496909B1/de not_active Expired - Lifetime
- 2003-04-14 DE DE60311788T patent/DE60311788T2/de not_active Expired - Fee Related
- 2003-04-14 US US10/511,744 patent/US20050215530A1/en not_active Abandoned
- 2003-04-14 ES ES03712464T patent/ES2280735T3/es not_active Expired - Lifetime
- 2003-04-14 JP JP2003585723A patent/JP2005530735A/ja active Pending
- 2003-04-14 CA CA002482591A patent/CA2482591A1/en not_active Abandoned
- 2003-04-14 WO PCT/GB2003/001617 patent/WO2003088971A1/en active IP Right Grant
-
2004
- 2004-10-13 IL IL16456404A patent/IL164564A0/xx unknown
- 2004-10-21 NO NO20044498A patent/NO20044498L/no not_active Application Discontinuation
-
2005
- 2005-05-23 HK HK05104297A patent/HK1071310A1/xx not_active IP Right Cessation
Also Published As
Publication number | Publication date |
---|---|
NO20044498L (no) | 2004-11-04 |
WO2003088971A1 (en) | 2003-10-30 |
EP1496909A1 (de) | 2005-01-19 |
ES2280735T3 (es) | 2007-09-16 |
KR20040103964A (ko) | 2004-12-09 |
CN100352441C (zh) | 2007-12-05 |
BR0309226A (pt) | 2005-02-09 |
HK1071310A1 (en) | 2005-07-15 |
AU2003216558A1 (en) | 2003-11-03 |
AU2003216558B2 (en) | 2008-05-29 |
JP2005530735A (ja) | 2005-10-13 |
MXPA04010166A (es) | 2005-02-03 |
CA2482591A1 (en) | 2003-10-30 |
NZ535739A (en) | 2008-01-31 |
EP1496909B1 (de) | 2007-02-14 |
US20050215530A1 (en) | 2005-09-29 |
DE60311788T2 (de) | 2007-11-22 |
CN1658880A (zh) | 2005-08-24 |
DE60311788D1 (de) | 2007-03-29 |
IL164564A0 (en) | 2005-12-18 |
Similar Documents
Publication | Publication Date | Title |
---|---|---|
HK1071310A1 (en) | Combination therapy for the treatment of cancer | |
ATE357236T1 (de) | Verwendung von dem quinazolin derivat zd6474 kombiniert mit gemcitabin und gegebenenfalls ionisierender strahlung für die behandlung von krebs | |
NO20071426L (no) | Kreft kombinasjonsbehandling omfattende AZD2171 og Imatinib | |
CY1111547T1 (el) | Συνδυασμος zd6474 και πεμετρεξεδης | |
IS6558A (is) | Blandaðar sjúkdómsmeðferðir með æðaskaðandi virkni | |
CY1111482T1 (el) | Συνδυασμος azd2171 και πεμετρεξεδης | |
NO20056170L (no) | Kreftkombinasjonsterapi omfattende AZD2171 of ZD1839 | |
NO20064755L (no) | Kombinasjonsterapi | |
NO20064753L (no) | Kombinasjonsterapi | |
NO20056171L (no) | Kombinasjonsterapi | |
NO20064754L (no) | Kombinasjonsterapi | |
MXPA05013827A (es) | Composiciones que comprenden zd6126 junto con 5-fu, cpt-11 o 5-fu y cpt-11, que tienen actividad de dano vascular, para tratar cancer colorectal e. g. | |
ATE339209T1 (de) | Kombinationstherapie mit gemzitabin und zd6126 |
Legal Events
Date | Code | Title | Description |
---|---|---|---|
RER | Ceased as to paragraph 5 lit. 3 law introducing patent treaties |